Lipid and lipoprotein dysregulation in insulin resistant states

RK Avramoglu, H Basciano, K Adeli - Clinica chimica acta, 2006 - Elsevier
Insulin resistant states are commonly associated with an atherogenic dyslipidemia that
contributes to significantly higher risk of atherosclerosis and cardiovascular disease. Indeed …

The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities

HS Kalia, PJ Gaglio - Clinics in liver disease, 2016 - liver.theclinics.com
During the last several decades, nonalcoholic fatty liver disease (NAFLD) has emerged as
an important cause of liver dysfunction. It is currently one of the most common causes of liver …

[PDF][PDF] Histopathology of pediatric nonalcoholic fatty liver disease

JB Schwimmer, C Behling, R Newbury, R Deutsch… - …, 2005 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are
common in children and adolescents. However, standard histological criteria for pediatric …

The effects of conjugated linoleic acid supplementation on liver function enzymes and malondialdehyde in adults: A GRADE-assessed systematic review and dose …

N Haghighat, G Shimi, F Shiraseb, A Karbasi… - Pharmacological …, 2022 - Elsevier
Background Previous research reported inconsistent findings regarding the effects of
conjugated linoleic acid (CLA) supplementation on liver enzymes. This systematic review …

[HTML][HTML] Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD)

SM Alavian, A Esmaillzadeh, P Adibi… - Hepatitis …, 2013 - ncbi.nlm.nih.gov
Background Dietary intake might have important role in non-alcoholic fatty liver diseases
(NAFLD). Although, there are some reports on dietary intake and anthropometrics …

Risk factors for the development of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including genetics

HW Lim, DE Bernstein - Clinics in Liver Disease, 2018 - liver.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is prevalent worldwide and is the most common
chronic liver disease in Western countries. Its increasing prevalence is associated with …

[HTML][HTML] Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non-Alcoholic Fatty Liver Disease

MH Somi, E Fatahi, J Panahi, MR Havasian - Bioinformation, 2014 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) consists of a range of complication. The disease
describes clinical, para clinical and pathological conditions from simple steatosis in non …

[HTML][HTML] Clinical manifestations and diagnosis of nonalcoholic fatty liver disease

M Khoonsari, MMH Azar, R Ghavam… - Iranian journal of …, 2017 - ncbi.nlm.nih.gov
Methods: Patients with NAFLD confirmed by ultrasonography were enrolled into the current
study. They had negative serologic markers of viral or autoimmune hepatitis, no findings in …

Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis

L Cao, Y An, H Liu, J Jiang, W Liu, Y Zhou, M Shi… - BMC medicine, 2024 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver
disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes …

[HTML][HTML] First multicenter study for risk factors for hepatocellular carcinoma development in North Africa

O Bahri, S Ezzikouri, NB Alaya-Bouafif… - World journal of …, 2011 - ncbi.nlm.nih.gov
AIM: To assess the role of the major risk factors for hepatocellular carcinoma (HCC)
development in the western part of North Africa. METHODS: A multicenter case control study …